Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.

The collage of faces of surprised people on coloured backgrounds.

This experimental medicine trial investigated the effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers.

Participants took atorvastatin for seven days and they were subsequently more likely to identify faces showing fearful emotions. 

The study results reveal for the first time the early influence of atorvastatin on emotional recognition of fear - something that is linked to anxiety and depression, as well as the effects of commonly-used antidepressants on these conditions.

Dr Riccardo De Giorgi, study author and Wellcome Trust Doctoral Training Fellow, University of Oxford, said:

 

'Our findings are important because they show for the first time that a very commonly prescribed medication, atorvastatin, can affect the way we perceive certain emotions. This is relevant to further studies investigating whether statins could be used for treating depressive and anxiety disorders.'

Read the full study, The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study, in the Journal of Psychopharmacology 

Similar stories

Protecting brains and minds in a transition away from fossil fuels

Senior Researcher Jessica Newberry Le Vay writes about new climate policy recommendations arising from the Transitioning Away from Fossil Fuels Conference.

'Three things I have learned in three years of being a #LivedExperienceScientist'

Professor Clare Mackay discusses what she's learned since revealing she lives with hair pulling disorder.

New shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure – major study indicates

The shingles vaccine currently in use, called ‘Shingrix’, is associated with a reduced risk of cardiovascular events – including heart attacks, heart failure and stroke – compared to the previous shingles vaccine, according to a major new study published in Nature Medicine.

Semaglutide associated with fewer cognitive problems in people with mental illness

Semaglutide, widely used to treat diabetes and obesity, was associated with fewer cognitive signs and symptoms in people with psychiatric disorders, according to a new study led by researchers at the University of Oxford.

New audit system maps how mental-health risks emerge in AI chatbot conversations

Scientists have developed a framework for stress-testing how AI chatbots respond to vulnerable users, helping researchers identify weaknesses and test ways of making mental-health interactions safer.

Salsa classes shown to reduce depressive symptoms in young adults

A new trial led by the University of Oxford suggests it may offer a promising, accessible addition to youth wellbeing support.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.